These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39134343)

  • 1. Long-term retention and positive deviant practices in Uganda's community client-led antiretroviral distribution groups (CCLADs): a mixed-methods study.
    Natukunda J; Baleeta K; Kiriya J; Ong KIC; Carandang RR; Muhwezi A; Shibanuma A; Jimba M
    BMJ Glob Health; 2024 Aug; 9(8):. PubMed ID: 39134343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Barriers and facilitators of male engagement in Community Client-Led Antiretroviral therapy Delivery groups (CCLADS) for HIV care and treatment in Southwestern Uganda: a qualitative study.
    Kushemererwa J; Muwanguzi M; Atukunda EC; Kikomeko HN; Ambrose O; Androdri D; Kembabazi B; Najjuma JN
    BMC Health Serv Res; 2022 Jan; 22(1):125. PubMed ID: 35093057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with long-term antiretroviral therapy attrition among adolescents in rural Uganda: a retrospective study.
    Okoboi S; Ssali L; Yansaneh AI; Bakanda C; Birungi J; Nantume S; Okullu JL; Sharp AR; Moore DM; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20841. PubMed ID: 27443271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing HIV treatment and support: a qualitative inquiry into client and healthcare provider perspectives on differential service delivery models in Uganda.
    Katongole SP; Mukama SC; Nakawesi J; Bindeeba D; Simons E; Mugisa A; Senyimba C; Namitala E; Onzima RADDM; Mukasa B
    AIDS Res Ther; 2024 Jul; 21(1):47. PubMed ID: 39068451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perceptions and factors associated with the uptake of the community client-led antiretroviral therapy delivery model (CCLAD) at a large urban clinic in Uganda: a mixed methods study.
    Walusaga HAG; Atuyambe LM; Muddu M; Mpirirwe R; Nangendo J; Kalibbala D; Semitala FC; Katahoire AR
    BMC Health Serv Res; 2023 Oct; 23(1):1165. PubMed ID: 37885014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retention and risk factors for attrition among adults in antiretroviral treatment programmes in Tanzania, Uganda and Zambia.
    Koole O; Tsui S; Wabwire-Mangen F; Kwesigabo G; Menten J; Mulenga M; Auld A; Agolory S; Mukadi YD; Colebunders R; Bangsberg DR; van Praag E; Torpey K; Williams S; Kaplan J; Zee A; Denison J
    Trop Med Int Health; 2014 Dec; 19(12):1397-410. PubMed ID: 25227621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term retention and predictors of attrition for key populations receiving antiretroviral treatment through community-based ART in Benue State Nigeria: A retrospective cohort study.
    Ibiloye O; Jwanle P; Masquillier C; Van Belle S; Jaachi E; Amoo O; Isah A; Omole T; Samuel JO; van Olmen J; Lynen L; Okonkwo P; Decroo T
    PLoS One; 2021; 16(11):e0260557. PubMed ID: 34847194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lessons for test and treat in an antiretroviral programme after decentralisation in Uganda: a retrospective analysis of outcomes in public healthcare facilities within the Lablite project.
    Kiwuwa-Muyingo S; Abongomera G; Mambule I; Senjovu D; Katabira E; Kityo C; Gibb DM; Ford D; Seeley J
    Int Health; 2020 Sep; 12(5):429-443. PubMed ID: 31730168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors that influence the satisfaction of people living with HIV with differentiated antiretroviral therapy delivery models in east Central Uganda: a cross-sectional study.
    Baleeta K; Muhwezi A; Tumwesigye N; Kintu BN; Riese S; Byonanebye D; Mbonye M; Mwehire D; Iriso R; Ayebazibwe B; Bailey L; Lopez D; McGough L; Etukoit M; Nantamu D; Nakitende L; Tibengana B; Wasswa J
    BMC Health Serv Res; 2023 Feb; 23(1):127. PubMed ID: 36750840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to enrolment of clients into community client led anti-retroviral therapy delivery (CCLAD) in selected health facilities in Kasese district, Uganda.
    Omona K; Kanyerezi AB
    Afr Health Sci; 2024 Mar; 24(1):42-58. PubMed ID: 38962335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV care retention in three multi-month ART dispensing: a retrospective cohort study in Mozambique.
    Saura-Lázaro A; Augusto O; Fernández-Luis S; López-Varela E; Fuente-Soro L; Bila D; Tovela M; Macuacua N; Vaz P; Couto A; Bruno C; Naniche D
    AIDS; 2024 Jul; 38(9):1402-1411. PubMed ID: 38652496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experiences and Perceptions on Community Client-Led ART Delivery (CCLADS) Model of Antiretroviral (ART) Delivery: Patients' and Providers' Perspectives in South Western Uganda.
    Kasande M; Taremwa M; Tusimiirwe H; Lamulatu K; Amanyire M; Nakidde G; Kabami J
    HIV AIDS (Auckl); 2022; 14():539-551. PubMed ID: 36425751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of successful retention in care among HIV-infected men in a universal test-and-treat setting in Uganda and Kenya: A mixed methods analysis.
    Brown LB; Getahun M; Ayieko J; Kwarisiima D; Owaraganise A; Atukunda M; Olilo W; Clark T; Bukusi EA; Cohen CR; Kamya MR; Petersen ML; Charlebois ED; Havlir DV; Camlin CS
    PLoS One; 2019; 14(1):e0210126. PubMed ID: 30673744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multilevel determinants of antiretroviral therapy initiation and retention in the test-and-treat era of Nepal: a qualitative study.
    Shrestha A; Poudel L; Shrestha S; Jha N; Kuikel BS; Shakya P; Kunwar RS; Pandey LR; Kc MB; Wilson EC; Deuba K
    BMC Health Serv Res; 2024 Aug; 24(1):927. PubMed ID: 39138448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attrition in HIV care following HIV diagnosis: a comparison of the pre-UTT and UTT eras in South Africa.
    Onoya D; Hendrickson C; Sineke T; Maskew M; Long L; Bor J; Fox MP
    J Int AIDS Soc; 2021 Feb; 24(2):e25652. PubMed ID: 33605061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention in care and factors critical for effectively implementing antiretroviral adherence clubs in a rural district in South Africa.
    Bock P; Gunst C; Maschilla L; Holtman R; Grobbelaar N; Wademan D; Dunbar R; Fatti G; Kruger J; Ford N; Hoddinott G; Meehan SA
    J Int AIDS Soc; 2019 Oct; 22(10):e25396. PubMed ID: 31588668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates and predictors of adherence and retention for antiretroviral therapy among HIV-positive adults in Enugu, Nigeria.
    Chime OH; Ndibuagu EO; Orji CJ
    Malawi Med J; 2019 Sep; 31(3):202-211. PubMed ID: 31839890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe's national antiretroviral therapy programme between 2012 and 2015.
    Makurumidze R; Mutasa-Apollo T; Decroo T; Choto RC; Takarinda KC; Dzangare J; Lynen L; Van Damme W; Hakim J; Magure T; Mugurungi O; Rusakaniko S
    PLoS One; 2020; 15(1):e0222309. PubMed ID: 31910445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced peer-group strategies to support the prevention of mother-to-child HIV transmission leads to increased retention in care in Uganda: A randomized controlled trial.
    Amone A; Gabagaya G; Wavamunno P; Rukundo G; Namale-Matovu J; Malamba SS; Lubega I; Homsy J; King R; Nakabiito C; Namukwaya Z; Fowler MG; Musoke P
    PLoS One; 2024; 19(4):e0297652. PubMed ID: 38640123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term retention on antiretroviral treatment after enrolment in prevention of vertical HIV transmission services: a prospective cohort study in Dar es Salaam, Tanzania.
    Urrio RF; Lyatuu GW; Sando D; Mahande MJ; Philipo E; Naburi H; Lyaruu P; Kimonge A; Mayogu K; Simba B; Kibao AM; Msangi M; Zeebari Z; Biberfeld G; Ekström AM; Kilewo C; Kågesten AE
    J Int AIDS Soc; 2024 Feb; 27(2):e26186. PubMed ID: 38332522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.